InspireMD Inc. (NSPR)
2.59
-0.01 (-0.38%)
At close: Apr 17, 2025, 3:59 PM
2.69
3.86%
After-hours: Apr 17, 2025, 07:53 PM EDT
-0.38% (1D)
| Bid | 2.47 |
| Market Cap | 76.9M |
| Revenue (ttm) | 7.01M |
| Net Income (ttm) | -32.01M |
| EPS (ttm) | -0.76 |
| PE Ratio (ttm) | -3.41 |
| Forward PE | -3.48 |
| Analyst | Buy |
| Ask | 2.69 |
| Volume | 61,770 |
| Avg. Volume (20D) | 57,127 |
| Open | 2.59 |
| Previous Close | 2.60 |
| Day's Range | 2.57 - 2.59 |
| 52-Week Range | 1.81 - 3.80 |
| Beta | 0.74 |
About NSPR
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, ...
Industry Medical - Devices
Sector Healthcare
IPO Date Apr 12, 2011
Employees 85
Stock Exchange NASDAQ
Ticker Symbol NSPR
Website https://www.inspiremd.com
Analyst Forecast
According to 2 analyst ratings, the average rating for NSPR stock is "Buy." The 12-month stock price forecast is $4.75, which is an increase of 83.40% from the latest price.
Stock ForecastsNext Earnings Release
InspireMD Inc. is scheduled to release its earnings on May 13, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+1.78%
InspireMD shares are trading higher after the comp...
Unlock content with
Pro Subscription
5 months ago
+5.46%
InspireMD shares are trading higher after the company reported better-than-expected Q3 financial results.
